Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

BACKGROUND: In the current study, we pooled imaging data in newly diagnosed glioblastoma (GBM) patients from international multicenter clinical trials, single institution databases, and multicenter clinical trial consortiums to identify the relationship between postoperative residual enhancing tumor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Ellingson, Benjamin M, Abrey, Lauren E, Nelson, Sarah J, Kaufmann, Timothy J, Garcia, Josep, Chinot, Olivier, Saran, Frank, Nishikawa, Ryo, Henriksson, Roger, Mason, Warren P, Wick, Wolfgang, Butowski, Nicholas, Ligon, Keith L, Gerstner, Elizabeth R, Colman, Howard, de Groot, John, Chang, Susan, Mellinghoff, Ingo, Young, Robert J, Alexander, Brian M, Colen, Rivka, Taylor, Jennie W, Arrillaga-Romany, Isabel, Mehta, Arnav, Huang, Raymond Y, Pope, Whitney B, Reardon, David, Batchelor, Tracy, Prados, Michael, Galanis, Evanthia, Wen, Patrick Y, Cloughesy, Timothy F
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Neuroimaging
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6071654/
https://ncbi.nlm.nih.gov/pubmed/29660006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy053
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados